Daxor
  • About Daxor
    • Company Overview
    • Executive Team
    • Board of Directors
    • Careers
    • Contact Us
  • The BVA-100
    • Importance Of Blood Volume Measurement
    • Blood Volume Measurement Test
    • Principle Of Blood Volume Measurement
    • Performing Blood Volume Measurement
    • Blood Volume Measurement Report
    • Resources
    • FAQ’s
  • Healthcare Professionals
    • COVID-19
    • Heart Failure
    • Critical Care
    • Other Indications
    • Clinical Evidence
    • Case Studies
    • The BVA Brief Newsletter
    • Reimbursement
    • Technical Resources
    • Clinical Support Team
  • Innovations
  • Investors
    • Tear Sheet
    • Press Releases
    • Executive Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • SEC Filings
    • FAQ’s
    • Key Contacts
  • Contact
  • About Daxor
    • Company Overview
    • Executive Team
    • Board of Directors
    • Careers
    • Contact Us
  • The BVA-100
    • Importance Of Blood Volume Measurement
    • Blood Volume Measurement Test
    • Principle Of Blood Volume Measurement
    • Performing Blood Volume Measurement
    • Blood Volume Measurement Report
    • Resources
    • FAQ’s
  • Healthcare Professionals
    • COVID-19
    • Heart Failure
    • Critical Care
    • Other Indications
    • Clinical Evidence
    • Case Studies
    • The BVA Brief Newsletter
    • Reimbursement
    • Technical Resources
    • Clinical Support Team
  • Innovations
  • Investors
    • Tear Sheet
    • Press Releases
    • Executive Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • SEC Filings
    • FAQ’s
    • Key Contacts
  • Contact
News
27 Jul 2022

Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Over-Year and Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.

admin
News
21 Jul 2022

Daxor Corporation Announces Partnership with MedAxiom to Advance Awareness & Further Adoption of Daxor’s Blood Volume Diagnostic (BVA-100®)

admin
News
18 Jul 2022

Daxor Completes NIH Funded I-Corps Program for Commercialization of Clinical Decision Support Software

admin
News
27 Jun 2022

Daxor Announces Cooperative Research & Development Phase II Agreement with the Uniformed Armed Services University for the Development of a Non-Nuclear Blood Volume Analysis (BVA) Device

admin
News
13 Jun 2022

Daxor Corporation to Showcase the Benefits of BVA-100® Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 18th Annual Meeting

admin
News
25 May 2022

Daxor’s Blood Volume Analyzer (BVA-100®) To Be Used As a Key Metric in Study of “Long Hauler” COVID-19 Patients

admin
News
12 May 2022

Daxor Corporation to Present at the H.C. Wainwright & Company Global Investment Conference

admin
News
02 May 2022

New Data Validates Blood Volume Analysis Guided-Care, Improves Survival in Patients with Advanced Heart Failure Supported with Left Ventricular Assist Device

admin
News
06 Apr 2022

New Study from Duke Heart Demonstrates the Unique Accuracy and Utility of Daxor’s Blood Volume Diagnostic (BVA-100®) for Improving Worsening Heart Failure

admin
News
23 Mar 2022

Daxor Corporation to Participate in the Maxim Group 2022 Virtual Growth Conference

admin
Previous
Next